Biomea Fusion, Inc.(BMEA)

$1.73—Stale · unknown old

Chart

Biomea Fusion, Inc.(BMEA)

NASDAQ • Last print unknown ago

$1.73—Stale · unknown old

Chart Studio

BMEA(BMEA)

BMEA

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.21

Nov 3, 2026

Analyst Sentiment

Wall St. Consensus

Buy

13 analysts·Moderate coverage

Score

10 Buy (77%)3 Hold (23%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

1077%

Hold

323%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$10.00

+478.0%

Consensus

$19.00

+998.3%

Bull

$40.00

+2212.1%

12-Month Target Range13 analysts

$10.00$19.00$40.00

Current $1.73Consensus

Current Price

$1.73

Upside to Consensus

$17.27

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev-62.76%

EPS—

FY2028

Rev+639.32%

EPS—

FY2029

Rev+7358.05%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$3M	$1M	$8M	$616M	$107M
Low	$3M	$1M	$8M	$616M	$107M
High	$3M	$1M	$8M	$616M	$107M
EBITDA Avg	$-43M	$-97M	$-40M	$-41M	$-31M
Low	$-52M	$-113M	$-43M	$-41M	$-31M
High	$-33M	$-29M	$-37M	$-41M	$-31M
EBIT Avg	$-44M	$-98M	$-40M	$-42M	$-31M
Low	$-54M	$-114M	$-43M	$-42M	$-31M
High	$-35M	$-30M	$-38M	$-42M	$-31M
Net Income Avg	$-44M	$-98M	$-40M	$-42M	$-31M
Low	$-54M	$-114M	$-43M	$-42M	$-31M
High	$-35M	$-30M	$-38M	$-42M	$-31M
EPS Avg	$-0.78	$-1.03	$-0.79	$-0.80	$-0.60
Low	$-1.03	$-2.19	$-0.83	$-0.80	$-0.60
High	$-0.66	$-0.57	$-0.72	$-0.80	$-0.60
Analysts (Rev / EPS)	6 / 4	7 / 4	5 / 3	2 / 1	2 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
EBITDA Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
EBIT Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
Net Income Avg	$-16M	$-22M	$-12M	$-12M	$-12M	$-13M	$-16M	$-15M
Low	$-24M	$-33M	$-12M	$-12M	$-12M	$-13M	$-16M	$-15M
High	$-13M	$-17M	$-12M	$-12M	$-12M	$-13M	$-16M	$-15M
EPS Avg	$-0.23	$-0.31	$-0.16	$-0.17	$-0.17	$-0.18	$-0.21	$-0.20
Low	$-0.33	$-0.45	$-0.16	$-0.17	$-0.17	$-0.18	$-0.21	$-0.20
High	$-0.18	$-0.23	$-0.16	$-0.17	$-0.17	$-0.18	$-0.21	$-0.20
Analysts (Rev / EPS)	— / 4	— / 4	— / 1	— / 1	— / 1	— / 1	— / 2	— / 2

Earnings Surprises

Recent Analyst Actions

Mar 24, 2025Oppenheimer

Biomea Fusion price target lowered to $10 from $50 at Oppenheimer

Target:$10.00

+258.4%from $2.79

Oct 31, 2024Piper Sandler

Biomea Fusion price target raised to $19 from $10 at Piper Sandler

Target:$19.00

+83.8%from $10.34

Oct 30, 2024Barclays

Biomea Fusion price target raised to $11 from $9 at Barclays

Target:$11.00

-8.8%from $12.06

Oct 22, 2024H.C. Wainwright

H.C. Wainwright Reiterates Buy Rating on Biomea Fusion Inc. (BMEA)

Target:$40.00

+255.9%from $11.24

Sep 27, 2024Piper Sandler

Piper Sandler Reiterates Overweight Rating on Biomea Fusion Inc. (BMEA)

Target:$10.00

+1.0%from $9.90

Jun 7, 2024H.C. Wainwright

Biomea Fusion price target lowered to $15 from $50 at H.C. Wainwright

Target:$15.00

+253.8%from $4.24

Jun 7, 2024Scotiabank

Biomea Fusion Inc. (BMEA) PT Lowered to $21 at Scotiabank

Target:$21.00

+86.3%from $11.27

Jun 7, 2024Barclays

Biomea Fusion downgraded to Equal Weight from Overweight at Barclays

Target:$5.00

-55.6%from $11.27

Jun 14, 2022H.C. Wainwright

Biomea Fusion (BMEA) Stock Price: $16 Target And Buy Rating

Target:$16.00

+88.2%from $8.50

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance